Business Standard

Jubilant Life Sciences standalone net profit rises 39.96% in the September 2018 quarter

Image

Capital Market

Sales rise 21.45% to Rs 878.31 crore

Net profit of Jubilant Life Sciences rose 39.96% to Rs 79.61 crore in the quarter ended September 2018 as against Rs 56.88 crore during the previous quarter ended September 2017. Sales rose 21.45% to Rs 878.31 crore in the quarter ended September 2018 as against Rs 723.20 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales878.31723.20 21 OPM %9.4515.40 -PBDT112.7499.40 13 PBT91.2178.27 17 NP79.6156.88 40

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 22 2018 | 4:52 PM IST

Explore News